scispace - formally typeset
Search or ask a question
Institution

Institute of Chartered Accountants of Nigeria

About: Institute of Chartered Accountants of Nigeria is a based out in . It is known for research contribution in the topics: Population & Adipose tissue. The organization has 528 authors who have published 579 publications receiving 18688 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: CAH patients and healthy control subjects exhibit significant differences in plasma metabolomes, which may be explained by glucocorticoid supplementation.
Abstract: Background. Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency leads to impaired cortisol biosynthesis. Treatment includes glucocorticoid supplementation. We studied the specific metabolomics signatures in CAH patients using two different algorithms. Methods. In a case-control study of CAH patients matched on sex and age with healthy control subjects, two metabolomic analyses were performed: one using MetaboDiff, a validated differential metabolomic analysis tool and the other, using Predomics, a novel machine-learning algorithm. Results. 168 participants were included (84 CAH patients). There was no correlation between plasma cortisol levels during glucocorticoid supplementation and metabolites in CAH patients. Indoleamine 2,3-dioxygenase enzyme activity was correlated with ACTH (rho coefficient = −0.25, p-value = 0.02), in CAH patients but not in controls subjects. Overall, 33 metabolites were significantly altered in CAH patients. Main changes came from: purine and pyrimidine metabolites, branched aminoacids, tricarboxylic acid cycle metabolites and associated pathways (urea, glucose, pentose phosphates). MetaboDiff identified 2 modules that were significantly different between both groups: aminosugar metabolism and purine metabolism. Predomics found several interpretable models which accurately discriminated the two groups (accuracy of 0.86 and AUROC of 0.9). Conclusion. CAH patients and healthy control subjects exhibit significant differences in plasma metabolomes, which may be explained by glucocorticoid supplementation.

3 citations

Book ChapterDOI
01 Jan 2013
TL;DR: This chapter reviews rodent models of obesity and how they provide crucial insight into the authors' understanding of physiological, environmental, genetic, and epigenetic bases of human obesity.
Abstract: This chapter reviews rodent models of obesity and how they provide crucial insight into our understanding of physiological, environmental, genetic, and epigenetic bases of human obesity. Naturally occurring or genetically modified animal models represent precious and necessary tools to explore the complexity of energy balance regulation and to test innovative therapeutic intervention in obesity, of which leptin treatment for leptin-deficient patients is a striking example.

3 citations

Journal ArticleDOI
TL;DR: In this paper, the effects of second-generation antipsychotics (SGAs) on fetal growth and body weight and their effects on metabolic regulation in the offspring have been investigated, and it has been shown that antenatal OLZ exposure induces multigenerational and gender-specific programming of glucose tolerance.

3 citations

Journal ArticleDOI
TL;DR: According to the ESC Guidelines, ivabradine should be considered when patients remain symptomatic despite the addition of a MCRA and when they have an increased heart rate (HR) ≥ 70 bpm in the context of sinus rhythm.
Abstract: Copyright © Polskie Towarzystwo Kardiologiczne INTRODUCTION The most recent version of the European Society of Cardiology (ESC) Guidelines for the management of heart failure (HF) has introduced two important innovations for the medical treatment of chronic HF with reduced ejection fraction (EF): mineralo-corticoid receptor antagonists (MCRA) and the If channel blocker ivabradine have now a recognised indication in patients remaining symptomatic despite diuretics, angiotensin converting enzyme inhibitors (or angiotensin receptor blockers in case of intolerance) and beta-blockers [1]. Mineralo-corticoid receptor antagonists are recommended following the EMPHASIS trial which demonstrated the benefit of eplerenone on cardiovascular mortality or HF hospitalisations as well as on all causes mortality in mild to moderate HF patients with reduced EF [2]. According to the ESC Guidelines, ivabradine should be considered when patients remain symptomatic despite the addition of a MCRA and when they have an increased heart rate (HR) ≥ 70 bpm in the context of sinus rhythm. This new recommendation derives from the results of the large outcome trial using this new agent, the SHIFT trial (Systolic Heart Failure Treatment with the If inhibitor Ivabradine trial) [3].

2 citations


Authors

Showing all 528 results

NameH-indexPapersCitations
Ronald M. Evans199708166722
Thierry Poynard11966864548
Heikki Joensuu10857150300
Gilles Montalescot10064158644
François Cambien9225136260
Antoine Danchin8048330219
Laurence Tiret7919425231
Karine Clément7827532185
Karine Clément7322814710
Pascal Ferré6924123969
Michael T. Osterholm6826022624
Vincent Jarlier6727817060
Florent Soubrier6722624486
Stephen H. Caldwell6630818527
Christian Funck-Brentano6426770432
Network Information
Related Institutions (5)
French Institute of Health and Medical Research
174.2K papers, 8.3M citations

86% related

University of Paris
174.1K papers, 5M citations

82% related

Beth Israel Deaconess Medical Center
52.5K papers, 2.9M citations

82% related

Brigham and Women's Hospital
110.5K papers, 6.8M citations

82% related

University of Lausanne
46.4K papers, 1.9M citations

81% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202168
202073
201950
201848
201793
201686